Sirio Pharma Co (SZSE:300791) Total Assets : ¥5,284 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sirio Pharma Co Total Assets?

Sirio Pharma Co's Total Assets for the quarter that ended in Sep. 2024 was ¥5,284 Mil.

Warning Sign:

If a company builds assets at 21% a year, faster than its revenue growth rate of 10.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Sirio Pharma Co's average Total Assets Growth Rate was 9.40% per year. During the past 3 years, the average Total Assets Growth Rate was 31.40% per year. During the past 5 years, the average Total Assets Growth Rate was 21.00% per year. During the past 10 years, the average Total Assets Growth Rate was 23.90% per year.

During the past 12 years, Sirio Pharma Co's highest 3-Year average Total Assets Growth Rate was 36.80%. The lowest was 9.90%. And the median was 20.50%.

Total Assets is connected with ROA %. Sirio Pharma Co's annualized ROA % for the quarter that ended in Sep. 2024 was 6.53%. Total Assets is also linked to Revenue through Asset Turnover. Sirio Pharma Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.20.

Sirio Pharma Co Total Assets Historical Data

The historical data trend for Sirio Pharma Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirio Pharma Co Total Assets Chart

Sirio Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

2,359.43

2,654.11

3,820.11

4,185.82

5,195.73

Sirio Pharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															4,902.66	5,195.73	5,127.43	5,165.47	5,283.99

Sirio Pharma Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sirio Pharma Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2566.169	+	2629.559
	=	5,196

Sirio Pharma Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	2573.438	+	2710.555
	=	5,284

Sirio Pharma Co (SZSE:300791) Total Assets Explanation

Total Assets is connected with ROA %.

Sirio Pharma Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	341.312	/	( (5165.471	+	5283.993)	/ 2 )
	=	341.312	/	5224.732
	=	6.53 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sirio Pharma Co's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	1057.978	/	( (5165.471	+	5283.993)	/ 2 )
=	1057.978	/	5224.732
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sirio Pharma Co Total Assets Related Terms

Thank you for viewing the detailed overview of Sirio Pharma Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirio Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 83, Taishan Road, Guangdong Province, Shantou, CHN, 515057

Website

http://www.siriopharm.com

Sirio Pharma Co Ltd is engaged in the research and development, production, sales and technical services of nutrition and health food, food production, sales, import and export of goods.

Executives

Chen Qiong	Directors, executives
Yao Zhuang Min	Directors, executives
Zheng Li Qun	Directors, executives
Yang Rui	Directors, executives

Sirio Pharma Co Headlines

No Headlines